Actionable Results and Turnaround Time Indicators for NSCLC Workflows ASCP 44:08 2 years ago 191 Далее Скачать
Considerations for duration and de-escalation of immunotherapy in lung cancer VJOncology 2:54 2 years ago 187 Далее Скачать
Benefits and Considerations for Genomic Profiling in NSCLC Thermo Fisher Scientific 17:29 4 years ago 124 Далее Скачать
NSCLC: Practical Considerations With Quadruplet Regimen Targeted Oncology 4:14 6 years ago 27 Далее Скачать
Case 2: Treatment Considerations in Stage IV NSCLC Targeted Oncology 4:15 6 years ago 39 Далее Скачать
Treatment Considerations in Non–Small Cell Lung Cancer Targeted Oncology 3:53 4 years ago 236 Далее Скачать
